Norges Bank Biomarin Pharmaceutical Inc Transaction History

Norges Bank

$716 Trillion
Q3 2024

49 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$74.43 - $92.22 $269 Million - $334 Million	3,619,503 New	3,619,503 $298 Million
Q4 2023 Feb 09, 2024	BUY	$76.22 - $98.51 $256 Million - $331 Million	3,361,310 New	3,361,310 $324 Million
Q3 2023 Nov 13, 2024	BUY	$85.07 - $94.48 $259 Million - $288 Million	3,043,300 New	3,043,300 $269 Million
Q3 2023 Nov 13, 2023	SELL	$85.07 - $94.48 $221 Million - $245 Million	-2,596,363 Closed	0 $0
Q2 2023 Aug 14, 2024	SELL	$86.68 - $100.3 $50.5 Million - $58.5 Million	-583,004 Reduced 16.11%	3,036,499 $263 Million
Q2 2023 Aug 14, 2023	SELL	$86.68 - $100.3 $222 Million - $257 Million	-2,563,636 Closed	0 $0
Q1 2023 May 15, 2024	BUY	$87.74 - $117.27 $253 Million - $338 Million	2,884,483 New	2,884,483 $280 Million
Q4 2022 Feb 14, 2023	BUY	$80.93 - $108.63 $223 Million - $299 Million	2,754,017 New	2,754,017 $285 Million
Q3 2022 Nov 13, 2023	BUY	$82.16 - $96.94 $213 Million - $252 Million	2,596,363 New	2,596,363 $220 Million
Q2 2022 Aug 14, 2023	BUY	$71.48 - $86.85 $183 Million - $223 Million	2,563,636 New	2,563,636 $212 Million
Q1 2022 May 12, 2023	SELL	$74.28 - $92.69 $14.5 Million - $18.1 Million	-195,719 Reduced 7.11%	2,558,298 $197 Million
Q1 2022 May 09, 2022	SELL	$74.28 - $92.69 $175 Million - $218 Million	-2,349,540 Closed	0 $0
Q4 2021 Mar 09, 2022	BUY	$71.72 - $91.47 $169 Million - $215 Million	2,349,540 New	2,349,540 $208 Million
Q3 2021 Nov 14, 2022	BUY	$74.77 - $85.47 $159 Million - $182 Million	2,125,847 New	2,125,847 $164 Million
Q3 2021 Nov 05, 2021	SELL	$74.77 - $85.47 $162 Million - $185 Million	-2,168,045 Closed	0 $0
Q2 2021 Aug 15, 2022	BUY	$75.51 - $84.79 $164 Million - $184 Million	2,168,045 New	2,168,045 $181 Million
Q2 2021 Aug 10, 2021	SELL	$75.51 - $84.79 $166 Million - $186 Million	-2,194,319 Closed	0 $0
Q1 2021 May 09, 2022	BUY	$74.73 - $90.69 $164 Million - $199 Million	2,194,319 New	2,194,319 $166 Million
Q1 2021 May 07, 2021	SELL	$74.73 - $90.69 $108 Million - $131 Million	-1,449,496 Closed	0 $0
Q4 2020 Mar 02, 2021	BUY	$72.61 - $90.2 $105 Million - $131 Million	1,449,496 New	1,449,496 $127 Million
Q4 2020 Feb 10, 2021	SELL	$72.61 - $90.2 $103 Million - $128 Million	-1,417,442 Closed	0 $0
Q3 2020 Nov 12, 2021	BUY	$71.87 - $131.03 $102 Million - $186 Million	1,417,442 New	1,417,442 $108 Million
Q3 2020 Nov 10, 2020	SELL	$71.87 - $131.03 $106 Million - $194 Million	-1,477,857 Closed	0 $0
Q2 2020 Aug 13, 2021	BUY	$79.55 - $124.22 $118 Million - $184 Million	1,477,857 New	1,477,857 $182 Million
Q2 2020 Aug 07, 2020	SELL	$79.55 - $124.22 $124 Million - $193 Million	-1,553,298 Closed	0 $0
Q1 2020 May 07, 2021	BUY	$71.37 - $96.85 $111 Million - $150 Million	1,553,298 New	1,553,298 $131 Million
Q1 2020 May 08, 2020	SELL	$71.37 - $96.85 $125 Million - $170 Million	-1,752,841 Closed	0 $0
Q4 2019 Mar 03, 2020	BUY	$64.27 - $86.37 $113 Million - $151 Million	1,752,841 New	1,752,841 $148 Million
Q4 2019 Feb 12, 2020	SELL	$64.27 - $86.37 $96.9 Million - $130 Million	-1,507,703 Closed	0 $0
Q3 2019 Nov 13, 2020	BUY	$67.4 - $85.11 $102 Million - $128 Million	1,507,703 New	1,507,703 $102 Million
Q3 2019 Nov 08, 2019	SELL	$67.4 - $85.11 $117 Million - $148 Million	-1,737,325 Closed	0 $0
Q2 2019 Aug 13, 2020	BUY	$80.35 - $93.9 $140 Million - $163 Million	1,737,325 New	1,737,325 $149 Million
Q2 2019 Aug 09, 2019	SELL	$80.35 - $93.9 $119 Million - $139 Million	-1,480,818 Closed	0 $0
Q1 2019 May 11, 2020	BUY	$84.2 - $98.62 $24.7 Million - $28.9 Million	293,094 Added 24.68%	1,480,818 $132 Million
Q4 2018 Mar 04, 2019	BUY	$80.14 - $106.07 $95.2 Million - $126 Million	1,187,724 New	1,187,724 $101 Million
Q4 2018 Feb 08, 2019	SELL	$80.14 - $106.07 $85.7 Million - $113 Million	-1,069,742 Closed	0 $0
Q3 2018 Nov 12, 2019	BUY	$93.92 - $105.72 $100 Million - $113 Million	1,069,742 New	1,069,742 $104 Million
Q3 2018 Nov 09, 2018	SELL	$93.92 - $105.72 $90.2 Million - $102 Million	-960,334 Closed	0 $0
Q2 2018 Aug 12, 2019	BUY	$76.01 - $99.03 $73 Million - $95.1 Million	960,334 New	960,334 $90.5 Million
Q2 2018 Jul 23, 2018	SELL	$76.01 - $99.03 $69.6 Million - $90.7 Million	-915,854 Closed	0 $0
Q1 2018 May 15, 2019	BUY	$77.67 - $92.63 $71.1 Million - $84.8 Million	915,854 New	915,854 $74.2 Million
Q1 2018 May 09, 2018	SELL	$77.67 - $92.63 $68.2 Million - $81.3 Million	-878,056 Closed	0 $0
Q4 2017 Mar 05, 2018	BUY	$80.76 - $95.13 $70.9 Million - $83.5 Million	878,056 New	878,056 $78.3 Million
Q4 2017 Feb 09, 2018	SELL	$80.76 - $95.13 $59.9 Million - $70.5 Million	-741,289 Closed	0 $0
Q3 2017 Nov 13, 2018	BUY	$80.6 - $94.95 $59.7 Million - $70.4 Million	741,289 New	741,289 $69 Million
Q3 2017 Nov 07, 2017	SELL	$80.6 - $94.95 $59.7 Million - $70.4 Million	-741,289 Closed	0 $0
Q2 2017 Jul 24, 2018	SELL	N/A	-195,124 Reduced 20.84%	741,289 $67.3 Million
Q1 2017 May 11, 2018	SELL	N/A	-50,967 Reduced 5.16%	936,413 $82.2 Million
Q3 2016 Nov 13, 2017	BUY	N/A	987,380	987,380 $0

Others Institutions Holding BMRN

# of Institutions

637

Shares Held

177M

Call Options Held

2.01M

Put Options Held

1.28M

Black Rock Inc. New York, NY

22.7M
Shares

$1.52 Billion
0.04% of portfolio
Vanguard Group Inc Valley Forge, PA

19.3M
Shares

$1.28 Billion
0.02% of portfolio
Primecap Management CO Pasadena, CA

18.9M
Shares

$1.26 Billion
0.99% of portfolio
Dodge & Cox San Francisco, CA

13.9M
Shares

$926 Million
0.59% of portfolio
Capital Research Global Investors Los Angeles, CA

10.5M
Shares

$699 Million
0.16% of portfolio

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $12.4B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

News

Stay updated on Norges Bank with notifications on news.

Account